DAIHAN Scientific Co., Ltd. (KOSDAQ:131220)
South Korea · Delayed Price · Currency is KRW 3,915.00
-20.00 (-0.51%)
At close: Jun 5, 2026
DAIHAN Scientific Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,308 | 3,281 | 2,693 | 3,845 | 4,702 | 3,767 |
Depreciation & Amortization | 1,750 | 1,782 | 1,840 | 1,838 | 1,689 | 1,552 |
Loss (Gain) From Sale of Assets | -55.98 | -70.09 | -20.3 | -9.53 | 35.37 | 32.79 |
Loss (Gain) From Sale of Investments | 1.07 | 2.03 | 1.86 | 39.69 | - | 12.45 |
Loss (Gain) on Equity Investments | -16.45 | -3.24 | -16.4 | -4.68 | -22.11 | 12.27 |
Provision & Write-off of Bad Debts | 31.18 | 39.23 | 3.1 | 143.41 | -18.31 | -13.62 |
Other Operating Activities | 1,903 | 1,866 | 1,319 | 1,040 | 1,396 | 1,980 |
Change in Accounts Receivable | -226.15 | -2,570 | -331.11 | -340.37 | 101.7 | -817.59 |
Change in Inventory | -244.71 | -390.17 | -1,813 | -2,095 | -2,047 | -4,419 |
Change in Accounts Payable | -324.5 | 297.89 | -583.27 | 102.38 | -1,644 | 2,101 |
Change in Other Net Operating Assets | 641.16 | 1,208 | 894.25 | 233.77 | 319.87 | -74.59 |
Operating Cash Flow | 6,766 | 5,444 | 3,987 | 4,793 | 4,512 | 4,132 |
Operating Cash Flow Growth | 52.39% | 36.52% | -16.80% | 6.21% | 9.20% | -22.70% |
Capital Expenditures | -420.23 | -315.25 | -440.22 | -624.25 | -3,039 | -3,192 |
Sale of Property, Plant & Equipment | 107.44 | 103.47 | 55.65 | 72.06 | 40.66 | 66.47 |
Cash Acquisitions | -52.91 | - | - | - | - | -150.08 |
Divestitures | - | - | - | 49.19 | - | - |
Sale (Purchase) of Intangibles | 59.35 | 63.75 | -53.89 | -21.52 | -38.63 | -32.98 |
Investment in Securities | -2,591 | -3,080 | -844.79 | -2,204 | -1,385 | -1,060 |
Other Investing Activities | - | - | 46.45 | 1.75 | 42.46 | 19.1 |
Investing Cash Flow | -2,897 | -3,228 | -1,237 | -2,727 | -4,380 | -4,350 |
Short-Term Debt Issued | - | 168.82 | 322.41 | - | 200 | 100 |
Long-Term Debt Issued | - | - | - | - | 595 | 1,905 |
Total Debt Issued | -1,255 | 168.82 | 322.41 | - | 795 | 2,005 |
Short-Term Debt Repaid | - | -322.41 | - | -120.51 | -240 | -40 |
Long-Term Debt Repaid | - | -1,698 | -1,796 | -451.55 | -487 | -425.98 |
Total Debt Repaid | -659.09 | -2,020 | -1,796 | -572.07 | -727 | -465.98 |
Net Debt Issued (Repaid) | -1,914 | -1,851 | -1,473 | -572.07 | 68 | 1,539 |
Repurchase of Common Stock | - | - | -1,000 | -500 | -499.99 | - |
Dividends Paid | -743.72 | -690.27 | -697.35 | -702.31 | -646.94 | -630.57 |
Other Financing Activities | -1.2 | -1.2 | 89 | 394.55 | 359.26 | - |
Financing Cash Flow | -2,659 | -2,543 | -3,082 | -1,380 | -719.67 | 908.45 |
Foreign Exchange Rate Adjustments | -7.56 | -24.78 | 4.65 | -43.53 | -13.84 | 1.45 |
Net Cash Flow | 1,202 | -351.57 | -326.39 | 642.24 | -600.65 | 691.89 |
Free Cash Flow | 6,346 | 5,128 | 3,547 | 4,169 | 1,474 | 939.76 |
Free Cash Flow Growth | 51.47% | 44.57% | -14.90% | 182.87% | 56.81% | -78.43% |
Free Cash Flow Margin | 7.64% | 6.32% | 4.95% | 5.66% | 2.04% | 1.42% |
Free Cash Flow Per Share | 925.60 | 747.62 | 508.52 | 588.88 | 205.94 | 130.71 |
Cash Interest Paid | 41.07 | 44.75 | 99.84 | 150.54 | 82.49 | 24.89 |
Cash Income Tax Paid | 856.16 | 683.05 | 839.67 | 1,557 | 1,328 | 300.8 |
Levered Free Cash Flow | 5,805 | 3,961 | 1,821 | 2,562 | -132.43 | -361.08 |
Unlevered Free Cash Flow | 5,831 | 3,988 | 1,880 | 2,657 | -98.99 | -334.54 |
Change in Working Capital | -154.2 | -1,453 | -1,833 | -2,100 | -3,269 | -3,210 |